ID   FCG3A_RAT               Reviewed;         249 AA.
AC   Q6XPU4; A0A0B4J2J1;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   24-JUL-2024, entry version 107.
DE   RecName: Full=Low affinity immunoglobulin gamma Fc region receptor III-A {ECO:0000250|UniProtKB:P08637};
DE            Short=IgG Fc receptor III-A;
DE   AltName: Full=CD16-2 {ECO:0000250|UniProtKB:A0A0B4J1G0};
DE   AltName: Full=FcgammaRIV {ECO:0000250|UniProtKB:A0A0B4J1G0};
DE   AltName: CD_antigen=CD16a;
DE   Flags: Precursor;
GN   Name=Fcgr3a {ECO:0000312|RGD:1303067}; Synonyms=Fcgr4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Teusner J.T., Belford D.A., Powell B.C.;
RT   "Identification of a novel rat receptor homologous to human FcgammaRIII-
RT   A.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
RA   Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
RA   Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L., Lu F.,
RA   Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C., Sutton G.G.,
RA   Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NOMENCLATURE.
RX   PubMed=7955033;
RA   Conrad D., Cooper M., Fridman W.H., Kinet J.P., Ravetch J.;
RT   "Nomenclature of Fc receptors. IUIS/WHO Subcommittee on Nomenclature of Fc
RT   receptors.";
RL   Bull. World Health Organ. 72:809-810(1994).
RN   [5]
RP   FUNCTION.
RX   PubMed=34485821; DOI=10.1093/abt/tbab016;
RA   Mao C., Near R., Zhong X., Gao W.;
RT   "Cross-species higher sensitivities of FcgammaRIIIA/FcgammaRIV to
RT   afucosylated IgG for enhanced ADCC.";
RL   Antib Ther 4:159-170(2021).
CC   -!- FUNCTION: Receptor for the invariable Fc fragment of immunoglobulin
CC       gamma (IgG). Binds with intermediate affinity to both IgG2a and IgG2b.
CC       Can bind to IgG2a and IgG2b monomers. Does not display binding to IgG1
CC       or IgG3 (By similarity). Recognizes neutralizing virus-specific IgGs
CC       displayed on the cell surface of infected cells and triggers antibody-
CC       dependent cellular cytotoxicity (ADCC). Confers protection to lethal
CC       influenza virus infection (By similarity). On splenic dendritic cells,
CC       uptakes antigen immune complexes and efficiently divert them into MHC
CC       class I and II antigen presentation pathways to provide for superior
CC       priming of CD4-positive and CD8-positive T cell immune responses (By
CC       similarity). Mediates neutrophil activation by IgG complexes
CC       redundantly with FCGR2A (By similarity). Plays a role in promoting bone
CC       resorption by enhancing osteoclast differentiation following binding to
CC       IgG2a (By similarity). Also acts as a receptor for the Fc region of
CC       immunoglobulin epsilon (IgE). Binds with low affinity to both the a and
CC       b allotypes of IgE. Has also been shown to bind to IgE allotype a only
CC       but not to allotype b. Binds aggregated IgE but not the monomeric form
CC       and bound monomeric IgG is readily displaced by IgE complexes. Binding
CC       to IgE promotes macrophage-mediated phagocytosis, antigen presentation
CC       to T cells, production of pro-inflammatory cytokines and the late phase
CC       of cutaneous allergic reactions (By similarity). Mediates enhanced ADCC
CC       in response to afucosylated IgGs (PubMed:34485821).
CC       {ECO:0000250|UniProtKB:A0A0B4J1G0, ECO:0000269|PubMed:34485821}.
CC   -!- SUBUNIT: Forms a heterooligomeric complex with ITAM-containing
CC       signaling subunits FCER1G. Interacts (via transmembrane domain) with
CC       signaling subunits; this interaction is a prerequisite for receptor
CC       complex expression on the cell surface and intracellular signal
CC       transduction. Binds the Fc region of antigen-complexed IgG.
CC       {ECO:0000250|UniProtKB:A0A0B4J1G0}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:A0A0B4J1G0};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:A0A0B4J1G0}.
CC   -!- PTM: Phosphorylated following receptor ligation.
CC       {ECO:0000250|UniProtKB:A0A0B4J1G0}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY219230; AAP44530.1; -; mRNA.
DR   EMBL; AC111734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473958; EDM09232.1; -; Genomic_DNA.
DR   RefSeq; NP_997486.1; NM_207603.1.
DR   RefSeq; XP_008767961.1; XM_008769739.2.
DR   AlphaFoldDB; Q6XPU4; -.
DR   SMR; Q6XPU4; -.
DR   STRING; 10116.ENSRNOP00000043183; -.
DR   GlyCosmos; Q6XPU4; 3 sites, No reported glycans.
DR   GlyGen; Q6XPU4; 3 sites.
DR   PhosphoSitePlus; Q6XPU4; -.
DR   PaxDb; 10116-ENSRNOP00000043183; -.
DR   GeneID; 304966; -.
DR   KEGG; rno:304966; -.
DR   AGR; RGD:1303067; -.
DR   CTD; 2214; -.
DR   RGD; 1303067; Fcgr3a.
DR   eggNOG; ENOG502RU1M; Eukaryota.
DR   HOGENOM; CLU_023383_1_0_1; -.
DR   InParanoid; Q6XPU4; -.
DR   OrthoDB; 5261894at2759; -.
DR   PhylomeDB; Q6XPU4; -.
DR   Reactome; R-RNO-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-RNO-2029481; FCGR activation.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:Q6XPU4; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Proteomes; UP000234681; Chromosome 13.
DR   Bgee; ENSRNOG00000024382; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0033001; C:Fc-gamma receptor III complex; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0019863; F:IgE binding; IEA:UniProtKB-KW.
DR   GO; GO:0019767; F:IgE receptor activity; ISO:RGD.
DR   GO; GO:0019864; F:IgG binding; IEA:UniProtKB-KW.
DR   GO; GO:0019770; F:IgG receptor activity; ISO:RGD.
DR   GO; GO:0140375; F:immune receptor activity; ISO:RGD.
DR   GO; GO:0019772; F:low-affinity IgG receptor activity; ISO:RGD.
DR   GO; GO:0001788; P:antibody-dependent cellular cytotoxicity; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:RGD.
DR   GO; GO:0002468; P:dendritic cell antigen processing and presentation; ISO:RGD.
DR   GO; GO:0160006; P:Fc receptor-mediated immune complex endocytosis; ISO:RGD.
DR   GO; GO:0038094; P:Fc-gamma receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042116; P:macrophage activation; ISO:RGD.
DR   GO; GO:0030101; P:natural killer cell activation; ISO:RGD.
DR   GO; GO:0043320; P:natural killer cell degranulation; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0042119; P:neutrophil activation; ISO:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045780; P:positive regulation of bone resorption; ISO:RGD.
DR   GO; GO:0032819; P:positive regulation of natural killer cell proliferation; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   CDD; cd05752; Ig1_FcgammaR_like; 1.
DR   CDD; cd05753; Ig2_FcgammaR_like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR050488; Ig_Fc_receptor.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR11481; IMMUNOGLOBULIN FC RECEPTOR; 1.
DR   PANTHER; PTHR11481:SF103; LOW AFFINITY IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR III-A-RELATED; 1.
DR   Pfam; PF13895; Ig_2; 2.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; IgE-binding protein;
KW   IgG-binding protein; Immunity; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..249
FT                   /note="Low affinity immunoglobulin gamma Fc region receptor
FT                   III-A"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5014221341"
FT   TOPO_DOM        21..203
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        204..224
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        225..249
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          31..103
FT                   /note="Ig-like C2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          117..188
FT                   /note="Ig-like C2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   SITE            217
FT                   /note="Important for receptor turnover"
FT                   /evidence="ECO:0000250|UniProtKB:P08637"
FT   MOD_RES         235
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B4J1G0"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        62
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        46..88
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        127..171
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        28
FT                   /note="N -> I (in Ref. 2; AC111734 and 3; EDM09232)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   249 AA;  28168 MW;  C58E6B2B97595D21 CRC64;
     MWYLLLPTAL LLTVSSGVGA GLQKAVVNLD PEWVRVLEED CVILRCQGTF SPEDNSTKWF
     HNKSLISHQD ANYVIQSARV KDSGMYRCQT AFSALSDPVQ LDVHADWLLL QTTKRLFQEG
     DPIRLRCHSW RNTPVFKVTY LQNGKGKKYF HRNSELSISK ATHADSGSYF CRGIIGRNNI
     SSASLQISIG DPTSPSSFLP WHQITFCLLI GLLFAIDTVL YFSVQRSLQS SVAVYEEPKL
     HWSKEPQDK
//
